Availability and Pricing of Drugs Prescribed by Otolaryngologists Through a Direct‐to‐Consumer Pharmacy: Medicare Savings Implications
Otolaryngology–Head and Neck Surgery · 2025
DOI: 10.1002/ohn.1023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2025. Verfasst von Taylor S Erickson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Medicare Part D, Drug Costs, Cost Savings, Prescription Drugs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
High prescription drug prices can financially strain patients and insurers, with substantial clinical repercussions. In recent years, direct‐to‐consumer (DTC) pharmacies have emerged as potentially lower‐cost alternatives for patients to fill prescriptions. We evaluated whether drugs commonly prescribed by otolaryngologists were available at a national DTC pharmacy (Mark Cuban Cost Plus Drug Company [MCCPDC]) and estimated potential Medicare savings from DTC pricing. We identified drugs and prices paid by Medicare Part D plans using the 2021 Drug Spending Dashboard. Our analysis included 16 generic drugs within the MCCPDC formulary, which offered lower prices for 14 (87.5%) drugs. If plans had secured MCCPDC pricing for all 16 drugs, Medicare patients and plans would have saved $2.9 billion (relative reduction: 62.3%) in 2021. Estimated total savings were greatest for budesonide‐formoterol ($1.9 billion), dexlansoprazole ($464.6 million), and levothyroxine ($327.4 million). Otolaryngologists and insurers may consider utilizing DTC pharmacies with lower drug prices, though patients may face challenges projecting out‐of‐pocket costs across pharmacies, medications, benefit phases, and formulary tiers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA.
- Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology and Sinus Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
- Department of Surgery, Ralph H. Johnson VA Medical Center, Charleston, South Carolina, USA.
- Department of Otolaryngology-Head and Neck Surgery, Division of Rhinology, Massachusetts Eye and Ear Infirmary, Boston, MA, USA.
- Department of Otolaryngology-Head and Neck Surgery, The Ohio State University Wexner Medical Center, Columbus, USA.
ORCID-Profile: Taylor S Erickson
Zitieren
APA
Erickson, T. S., Pletcher, S. D., Soler, Z. M., Schlosser, R. J., Workman, A. D., & Rathi, V. K. (2025). Availability and Pricing of Drugs Prescribed by Otolaryngologists Through a Direct‐to‐Consumer Pharmacy: Medicare Savings Implications. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.1023
Vancouver
Erickson TS, Pletcher SD, Soler ZM, Schlosser RJ, Workman AD, Rathi VK. Availability and Pricing of Drugs Prescribed by Otolaryngologists Through a Direct‐to‐Consumer Pharmacy: Medicare Savings Implications. Otolaryngology–Head and Neck Surgery. 2025. doi:10.1002/ohn.1023
BibTeX
@article{Erickson2025,
author = {Erickson, Taylor S and Pletcher, Steven D and Soler, Zachary M and Schlosser, Rodney J and Workman, Alan D and Rathi, Vinay K},
title = {Availability and Pricing of Drugs Prescribed by Otolaryngologists Through a Direct‐to‐Consumer Pharmacy: Medicare Savings Implications},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2025},
doi = {10.1002/ohn.1023}
}
EUVIMED